Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristian Rodriguez

Showing results (121-130 of 149) with videos related to

Pageof 15
Sort By:
Cell Reports. Medicine|September 4, 2025
Epigenetic modulation of BARD1 to enhance anti-VEGF therapyEmine Bayraktar, Cristian Rodriguez-Aguayo, Elaine Stur, et al.
Nature Communications|July 28, 2018
FABP4 as a key determinant of metastatic potential of ovarian cancerKshipra M Gharpure, Sunila Pradeep, Marta Sans, et al.
Nature Communications|February 4, 2018
Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylationYiyan Zheng, Ritika Sethi, Lingegowda S Mangala, et al.
Cell Reports|November 3, 2016
Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine CancersHiroto Hatakeyama, Sherry Y Wu, Yasmin A Lyons, et al.
Nature Communications|June 18, 2015
The ZNF304-integrin axis protects against anoikis in cancerBurcu Aslan, Paloma Monroig, Ming-Chuan Hsu, et al.
Cancer Cell|December 10, 2014
Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancersPradeep Chaluvally-Raghavan, Fan Zhang, Sunila Pradeep, et al.
Nature Communications|June 5, 2020
Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progressionRajesha Rupaimoole, Sherry Y Wu, Sunila Pradeep, et al.
Nature Communications|October 30, 2014
Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progressionRajesha Rupaimoole, Sherry Y Wu, Sunila Pradeep, et al.
Nature Communications|June 1, 2022
The androgen receptor is a therapeutic target in desmoplastic small round cell sarcomaSalah-Eddine Lamhamedi-Cherradi, Mayinuer Maitituoheti, Brian A Menegaz, et al.
The Prostate|September 4, 2025
Prostate-Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone-Sensitive Prostate Cancer Treated With ApalutamideChristian Andrés Martínez Osorio, Raquel Sopeña Sutil, Antoni Vilaseca Cabo, et al.
Pageof 15

Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
Cell Reports. Medicine|September 4, 2025
Epigenetic modulation of BARD1 to enhance anti-VEGF therapyEmine Bayraktar, Cristian Rodriguez-Aguayo, Elaine Stur, et al.
Nature Communications|July 28, 2018
FABP4 as a key determinant of metastatic potential of ovarian cancerKshipra M Gharpure, Sunila Pradeep, Marta Sans, et al.
Nature Communications|February 4, 2018
Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylationYiyan Zheng, Ritika Sethi, Lingegowda S Mangala, et al.
Cell Reports|November 3, 2016
Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine CancersHiroto Hatakeyama, Sherry Y Wu, Yasmin A Lyons, et al.
Nature Communications|June 18, 2015
The ZNF304-integrin axis protects against anoikis in cancerBurcu Aslan, Paloma Monroig, Ming-Chuan Hsu, et al.
Cancer Cell|December 10, 2014
Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancersPradeep Chaluvally-Raghavan, Fan Zhang, Sunila Pradeep, et al.
Nature Communications|June 5, 2020
Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progressionRajesha Rupaimoole, Sherry Y Wu, Sunila Pradeep, et al.
Nature Communications|October 30, 2014
Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progressionRajesha Rupaimoole, Sherry Y Wu, Sunila Pradeep, et al.
Nature Communications|June 1, 2022
The androgen receptor is a therapeutic target in desmoplastic small round cell sarcomaSalah-Eddine Lamhamedi-Cherradi, Mayinuer Maitituoheti, Brian A Menegaz, et al.
The Prostate|September 4, 2025
Prostate-Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone-Sensitive Prostate Cancer Treated With ApalutamideChristian Andrés Martínez Osorio, Raquel Sopeña Sutil, Antoni Vilaseca Cabo, et al.
Pageof 15